Account
Publications
25.10.2023
ISPOR Europe 2023: Are Acute Therapies And Curativ...

We've updated our 2019 analysis which compares the annual and lifetime treatment costs of the 10 mos...

Read more
Publications
25.10.2023
ISPOR Europe 2023: Can Just Three PICOs be Feasibl...

This research aims to understand if just three PICOs are feasible by analysing recent HTA assessment...

Read more
Publications
25.10.2023
ISPOR Europe 2023: How Aware Are Biotech and Pharm...

Our research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in...

Read more
Publications
25.10.2023
ISPOR Europe 2023: Evaluation and Reimbursement of...

Our study compares and contrasts the evaluation and reimbursement pathways for digital therapeutics ...

Read more
Publications
25.10.2023
ISPOR Europe 2023: How Has NICE’s Severity M...

Our study aims to understand how the severity modifier has been implemented so far and its impact on...

Read more
Publications
10.05.2023
ISPOR US 2023: Plenary Session 2 – AI wants ...

Our experts provide a detailed summary of Plenary Session 2 at ISPOR Annual 2023 on artificial intel...

Read more
Publications
09.05.2023
ISPOR US 2023: Plenary Session 1 – Global Fo...

Our experts provide a detailed summary of Plenary Session 1 at ISPOR Annual 2023 on global affordabi...

Read more
Publications
21.04.2023
ISPOR US 2023: How do the reimbursement opportunit...

Our research compares and contrasts the reimbursement landscapes of digital health applications (DHA...

Read more
Publications
09.11.2022
ISPOR 2022 Plenary Session 3 - Integrating Data

Our experts provide a detailed summary of Plenary Session 2 at ISPOR 2022 on innovative methods for ...

Read more
Publications
08.11.2022
ISPOR 2022 Plenary Session 2 - Real-World Research

Introduction Real World Data is being increasingly used across the globe to support medical-product ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.